Miami Cancer Institute Immunotherapies Summit for Hematologic Malignancies, Seventh Annual

March 6, 2026 to March 7, 2026
 

Live, In-person Symposium
Friday-Saturday, March 6-7, 2026
JW Marriott Miami, Miami, FL

Given the increasing frequency of hematologic malignancies and the complexities of treatments with novel agents, particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision-making and management, therefore, have become more complex.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma by novel immunotherapies, stem cell transplantation and treatment combinations. Updates on evolving immunologically and molecular-based system therapies will be profiled and discussed.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

  • Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
  • Provide an update of new molecular and immunological treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
  • Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.

Who Should Attend

This symposium is directed toward hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, oncology and hematology nurses, pharmacists and other allied health-care team members interested in the treatment of patients with hematologic malignancies.

Registration and Fees

 Before February 6, 2026After February 6, 2026
Physicians*$338$375
Advanced Practice Providers$175$195
Residents and Fellows**$121$135
Baptist Health Employees$99$110
Others$203$225

* 20% Group discounts available for three or more providers who register together as a group by Friday, February 6, 2026. No add-ons. Call for details.

** Registration must be accompanied by a letter from the Fellowship/Residency Director.

Event date: Friday-Saturday, March 6-7, 2026

Cancellation Policy

Cancellations must be received by Friday, February 20, 2026, to receive a refund of the registration fee, less a $35 administrative fee. Registration fees are not refundable after Friday, February 20, 2026.

Course Summary
Course opens: 
11/21/2025
Course expires: 
03/07/2026
Event starts: 
03/06/2026 - 8:30am EST
Event ends: 
03/07/2026 - 1:15pm EST
Cost:
$1.00

Agenda

Friday, March 6 - 6.5 Cat. 1

7:30 - 8:30 a.m.Registration, Breakfast and Visit Exhibits
8:30 - 8:45 a.m. Welcome and Introductions
Guenther Koehne, M.D., Ph.D.
Multiple Myeloma
8:45 - 9:05 a.m.Maintenance Therapy Post Autologous Transplants: Does MRD status Affect the Treatment Choice?
Saad Usmani, M.D.
9:05 - 9:25 a.m.Redirecting Therapies for Relapsed/Refractory Multiple Myeloma by CAR T and Bites
Adam Cohen, M.D.
9:25 - 9:45 a.m. Integration of CellMods into Treatment Approaches for Multiple Myeloma
Paul Richardson, M.D.
9:45 - 10:05 a.m. Insights on Adapting Treatments for Multiple Myeloma with New Immunotherapies in Countries with Limited or Intermediate Resources
Patricio Duarte, M.D.
10:05 - 10:25 a.m. How to Treat AL Amyloidosis in 2026
Heather Landau, M.D.
10:25 - 10:45 a.m.Panel Discussion
Usmani, Cohen, Richardson, Duarte, Landau
10:45 - 11:05 a.m.Break and Exhibits
B- and T-Cell Malignancies
11:05 - 11:25 a.m.Novel Therapies in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
Matthew Matasar, M.D.
11:25 - 11:45 a.m. Novel therapies in Chronic Lymphocytic Leukemia (CLL)
Craig Sauter, M.D.
11:45 - 12:05 p.m.How to Treat T-Cell Lymphoma in 2026
Steven M. Horwitz, M.D.
12:05 - 12:20 p.m.Panel Discussion
Matasar, Sauter, Horwitz
12:20 - 12:50 p.m.Lunch and Exhibits 
12:50 - 1:20 p.m.Product Theater
Acute Leukemia
1:20 - 1:40 p.m.Overcoming Treatment Resistance in T-All: Translation to the Clinic
Wendy Stock, M.D.
1:40 - 2:00 p.m.AML 2026: Is 7+3 Still The Standard of Care?
Richard Stone, M.D.
2:00 - 2:20 p.m.Updates on Targeted Therapies in Acute Myeloid Leukemia
Eytan Stein, M.D.
2:20 - 2:40 p.m.LYT-200 An Anti-Galectin 9 Antibody, for Treatment of AML/High-risk
Aleksandra Filipovic, M.D., Ph.D.
2:40 - 2:55 p.m.Panel Discussion
Stock, Stone, Stein, Filipovic
2:55 - 3:10 p.m.Break and Exhibits
Myeloproliferative Disorders
3:10 - 3:30 p.m.Novel Therapeutic Strategies in Myelofibrosis
Raajit K. Rampal, M.D., Ph.D.
3:30 - 3:50 p.m.The Role of Menin Inhibitors in Myelofibrosis
Firas El Chaer, M.D.
3:50 - 4:10 p.m.Myelofibrosis: Who to Transplant and Who Not to Transplant?
Nicolaus Kroeger, M.D.
4:10 - 4:25 p.m.Panel Discussion
Rampal, El Chaer, Kroeger
4:25 - 4:35 p.m.Closing Remarks/Adjourn
Guenther Koehne, M.D., Ph.D.
4:35 - 5:05 p.m. Product Theater

Saturday, March 7 - 3.5 Cat. 1

8:00 – 8:30 a.m. Registration and Breakfast
Updates on CAR Therapies
8:30 – 8:50 a.m. Next Steps in CAR T-Cell Therapies
Michel Sadelain, M.D.
8:50 – 9:10 a.m.Optimizing CAR T-Cell Homing via GPS
Robert Sackstein, M.D., Ph.D.
9:10 – 9:30 a.m.Do CARs Always Have to be T-Cells?
Paul Lin, M.D.
9:30 – 9:45 a.m.Panel Discussion
Sadelain, Sackstein, Lin
9:45 – 10:00 a.m.Break and Visit Exhibits
10:00 – 10:30 a.m.Product Theater
Allogeneic Stem Cell Transplants
10:30 – 10:50 a.m.Myelodysplastic Syndrome (MDS): Who to Transplant and Who Not to Transplant?
Mary M. Horowitz, M.D.
10:50 – 11:10 a.m.The Role of Intestinal Microbiome in Cancer Immunotherapy
Marcel R.M. van den Brink, M.D., Ph.D.
11:10 – 11:30 a.m.Novel Approaches to GVHD Prevention and Therapy
Corey Cutler, M.D.
11:30– 11:45 a.m.Break and Visit Exhibits
11:45 – 12:05 p.m.Updates on Allo BMT
Robert Soiffer, M.D.
12:05 – 12:25 p.m.Redefining prevention—what's next for GVHD prophylaxis?
Leo Luznik, M.D.
12:25 – 12:45 p.m.Is it time for post-transplant maintenance therapies in AML?
Guenther Koehne, M.D., Ph.D.
12:45 – 1:05 p.m.Panel Discussion
Horowitz, van den Brink, Cutler, Soiffer, Luznik, Koehne
1:05 – 1:15 p.m.Closing Remarks and Adjourn

NOTE: Schedule subject to change.

JW Marriott Miami
Miami, FL
United States

image

JW Marriott Miami

1109 Brickell Avenue
Miami, Florida 33131
United States
+1 (305) 329-3500


About the Venue

The JW Marriott Miami is located in the heart of Brickell, Miami's trendy destination for dining, shopping, and nightlife and is located a short walk away from the popular shopping and entertainment destination, Brickell City Centre. Guests are not far from all that Miami has to offer including the Perez Art Museum, Frost Science Museum, Kaseya Center (home of the Miami Heat), Adrienne Arsht Center, Port of Miami, South Beach, Coral Gables, Coconut Grove and Miami International Airport.

Rooms Rates and Highlights

  • 399.00 USD per night - Last Day to Book: Thursday, February 12, 2026
  • 24-hour room service - Free Wi-Fi for Marriott Bonvoy members - Complimentary fitness center access - Spa - Pool - Business Center

Travel Information

The drive time between the JW Marriott Miami and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 8.2 miles.

Services + Amenities

Relax with a facial or full body massage by an expert therapist at Salus Spa. Afterward, continue to unwind in the warmth of the Miami sun at the JW Marriott Miami's stainless steel sky pool.

Adjacent to The Spa is our Fitness Studio, the perfect escape for an energizing workout, featuring state-of-art equipment and free weights.

Dining

Isabela's
With its natural light and views of Brickell Ave, Isabela's is the perfect place to start the day.

La Terraza Cafe & Bar
With its Plasma TV's and LED Screens tuned to popular sporting events & delicious casual fare served at lunch, dinner, and weekend Brunch makes La Terraza the ideal place to unwind with friends and family.


Downtown Miami and Brickell

Greater Miami is synonymous with beautiful beaches and towering palm trees - but in its urban center, it is the cityscape of glittering skyscrapers over Biscayne Bay that gets all the attention. Diverse, dynamic and densely populated, Downtown Miami and the adjoining Brickell area is a hub of international finance, dining, arts and entertainment that no visitor should miss.

Explore Downtown Miami and BrickellExplore Miami

Symposium Director

image
Guenther Koehne, M.D., Ph.D.
Deputy Director and Chief of Stem Cell Transplantation
Hematologic Oncology and Benign Hematology
Baptist Health, Miami Cancer Institute
Miami, Florida 

Faculty

image
Adam D. Cohen, M.D.
Associate Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
image
Corey Cutler, M.D.
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
image
Patricio Duarte, M.D.
Associate Professor of Hematology
Instituto Universitario CEMIC
Bueno Aires, Argentina
image
Firas El Chaer, M.D.
Chief of Leukemia and
Medical Director of Infusion
Baptist Health, Miami Cancer Institute
Miami, Florida
image
Aleksandra Filipovic, M.D., Ph.D.
Department of Surgery and Cancer
Imperial College of London
London, England
image
Mary M. Horowitz, M.D.
Robert A. Uilhlein, Jr. Chair in Hematologic Research
Deputy Cancer Center Director
Medical College of Wisconsin
Scientific Director Emeritus Center for International Blood and Marrow Transplant Research
Milwaukee, Wisconsin
image
Steven M. Horwitz, M.D.
Lymphoma Specialist and Cellular Therapist
Memorial Sloan Kettering Cancer Center
New York, New York
image
Nicolaus Kroger, M.D.
Professor of Medicine
Medical Director of the Department of Stem Cell Transplantation
University Medical Center
Hamburg-Eppendorf
Hamburg, Germany 
image
Heather Landau, M.D.
Hematology Oncology
Bone Marrow Transplant Specialist and Cellular Therapists
Memorial Sloan Kettering Cancer Center
New York, New York 
image
Paul Lin, M.D.
Assistant Professor of Medicine
Multiple Myeloma and Cellular Therapy
MD Anderson Cancer Center
Houston, Texas 
image
Leo Luznik, M.D.
Professor of Oncology
Johns Hopkins Medicine
Baltimore, Maryland 
image
Matthew J. Matasar, M.D.
Chief, Division of Blood Disorders
Rutgers CINJ and RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
image
Raajit K. Rampal, M.D., Ph.D.
Associate Member and Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York
image
Paul G. Richardson, M.D.
Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
image
Robert Sackstein, M.D., Ph.D.
Tenured – Professor
Department of Cellular and Molecular Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida 
image
Michel Sadelain, M.D.
Director of the Columbia Initiative in
Cell Engineering and Therapy
Director of Cancer Cell Therapy Initiative
Herbert and Florence Irving Professor of Medicine
Columbia University
New York, New York 
image
Craig Sauter, M.D.
Hematology and Medical Oncology
Director, Blood and Marrow Transplant Program
Cleveland Clinic Main Campus
Cleveland, Ohio
image
Robert Soiffer, M.D.
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
image
Eytan Stein, M.D.
Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
image
Wendy Stock, M.D.
Anjuli Seth Nayak
Professor of Leukemia Research
University of Chicago
Chicago, Illinois 
image
Richard Stone M.D.
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
image
Saad Usmani, M.D.
Chief of Myeloma Service at
Memorial Sloan Kettering Cancer Center
Professor at Weill Cornell Medical College
New York, New York 
image
Marcel R.M. van den Brink, M.D., Ph.D.
President of City of Hope Los Angeles
National Medical Center
Los Angeles, California

NOTE: Faculty subject to change.

Price

Cost:
$1.00
Please login or register for a Baptist Health CME account to take this course.

Please make sure Payment amount is correct in the checkout.  If it is $1.00, it is not correct and you will need to remove it and re-add it.  For any issues please call the office at 786-596-2398